{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibitor of NF kappab)", "item": "https://www.patentleaderboard.com/patent/7893026"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibitor of NF kappab)

Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibitor of NF kappab)

US Patent 7893026 · Granted Feb 22, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-fungal polypeptides2024
TSLP inhibitors2021
Biological materials related to HER32020
IL-33R and IL-1RAcP fusion proteins2020
Sequences directed against hepatocyte growth factor (HGF) and polypeptides compr2018
Amino acid sequences directed against HER2 and polypeptides comprising the same 2018
Biological materials related to HER32018
Sequences directed against hepatocyte growth factor (HGF) and polypeptides compr2017
Amino acid sequences directed against HER2 and polypeptides comprising the same 2015
Inhibitors of MALT1 proteolytic activity and uses thereof2012
Peptides capable of binding to serum proteins and compounds, constructs and poly2012
Serum albumin binding proteins2012